British HIV Association guidelines for antiretroviral treatment of HIV-2-positive individuals 2010

HIV Med. 2010 Nov;11(10):611-9. doi: 10.1111/j.1468-1293.2010.00889.x.

Authors

Y Gilleece¹, D R Chadwick, J Breuer, D Hawkins, E Smit, L X McCrae, D Pillay, N Smith, J Anderson; BHIVA Guidelines Subcommittee

Collaborators

BHIVA Guidelines Subcommittee:
Jane Anderson, Yvonne Gilleece, Judith Breuer, David Hawkins, Erasmus Smit, Li Xu McCrae, David Chadwick, Deenan Pillay, Nicola Smith

Affiliation

¹ British HIV Association (BHIVA), BHIVA Secretariat, Mediscript Ltd, London, UK. [email protected]

PMID: 20961377
DOI: 10.1111/j.1468-1293.2010.00889.x

No abstract available

Publication types

Practice Guideline

MeSH terms

AIDS Serodiagnosis / methods
Anti-HIV Agents / therapeutic use*
CD4 Lymphocyte Count
Drug Administration Schedule
Drug Resistance, Viral / genetics*
Drug Therapy, Combination
Female
HIV Infections* / diagnosis
HIV Infections* / drug therapy
HIV Infections* / etiology
HIV-2*
Humans
Inhibitory Concentration 50
Microbial Sensitivity Tests
Mutation
Pregnancy
RNA, Viral / analysis
Reverse Transcriptase Inhibitors / therapeutic use*
Treatment Failure
Viral Load*

Substances

Anti-HIV Agents
RNA, Viral
Reverse Transcriptase Inhibitors